Rethinking CNS disorders: time for new drug targets?

被引:15
|
作者
Kalueff, Allan V. [1 ,2 ]
Stewart, Adam Michael [1 ,3 ]
Gottesman, Irving I. [4 ]
机构
[1] ZENEREI Inst, Slidell, LA 70458 USA
[2] Guangdong Ocean Univ, Res Inst Marine Drugs & Nutr, Zhanjiang 524025, Guangdong, Peoples R China
[3] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA
[4] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA
关键词
ANIMAL-MODELS; ENDOPHENOTYPES;
D O I
10.1016/j.tips.2014.07.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:491 / 492
页数:2
相关论文
共 50 条
  • [31] Neurotransmitter transporters: fruitful targets for CNS drug discovery
    L Iversen
    Molecular Psychiatry, 2000, 5 : 357 - 362
  • [32] Translational Drug Development for Pediatric CNS Disorders
    Potter, William
    Grabb, Meg
    Pandina, Gahan
    Jeste, Shafali
    Di Martino, Adriana
    Gur, Raquel
    Hornik, Christoph
    Mantua, Valentina
    Taylor-Zapata, Perdita
    Umbricht, Daniel
    NEUROPSYCHOPHARMACOLOGY, 2021, 46 (SUPPL 1) : 6 - 6
  • [33] Immune surveillance of the CNS: New concepts, new targets
    Richard, Ransohoff M.
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 147 - 148
  • [34] Purinergic drug targets for gastrointestinal disorders
    Burnstock, Geoffrey
    Jacobson, Kenneth A.
    Christofi, Fievos L.
    CURRENT OPINION IN PHARMACOLOGY, 2017, 37 : 131 - 141
  • [35] Drug targets for psychiatric disorders - Foreword
    Peter, J
    Burbach, H
    Adan, RAH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 480 (1-3) : 1 - 1
  • [36] Molecular drug targets for bipolar disorders
    Manji, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S87 - S89
  • [37] Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disorders
    Berend Malchow
    Jens Wiltfang
    Journal of Neural Transmission, 2023, 130 : 987 - 988
  • [38] Drug repurposing and new drug targets: perspectives for novel treatment options in mental health disorders
    Malchow, Berend
    Wiltfang, Jens
    JOURNAL OF NEURAL TRANSMISSION, 2023, 130 (08) : 987 - 988
  • [39] Histaminergic Drugs Could be Novel Targets for Neuroprotection in CNS Disorders
    Sharma, Hari S.
    Skaper, Stephen D.
    Sharma, Aruna
    CNS & Neurological Disorders-Drug Targets, 2016, 15 (06) : 642 - 643
  • [40] CNS NICOTINIC RECEPTORS - POSSIBLE THERAPEUTIC TARGETS IN NEURODEGENERATIVE DISORDERS
    COURT, JA
    PERRY, EK
    CNS DRUGS, 1994, 2 (03) : 216 - 233